Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
Ryosuke Oki(Tokushima University), Kazumoto Shibuya(Chiba University), Kazuyuki Noda(Juntendo University Shizuoka Hospital), Satoshi Sakaguchi(Tokushima University Hospital), Ryosuke Miyamoto(Tokushima University), Satoshi Kuwabara(Chiba University), Tomohiko Ishihara, Yuki Hatanaka(Teikyo University), Nobutaka Hattori(RIKEN Center for Brain Science), Ryuji Kaji(Kyoto University), Satoshi Teramukai(Kyoto University Hospital), Kazuto Nishinaka(Sumitomo Hospital), Makiko Nagai(Kitasato University), Hiroshi Nokihara(Tokushima University Hospital), Osamu Kano(Toho University), Hirokazu Furuya(National Institute of Health Sciences), Yasutaka Sato(Tokushima University Hospital), Hitoshi Kikuchi, Yoshiaki Nakayama(Wakayama Medical University), Ken Ikeda(Toho University), Tatsushi Toda(Osaka University), Yuishin Izumi(Tokushima University), Hirofumi Maruyama(Hiroshima University), Hiroaki Yanagawa(Tokushima University Hospital), Gen Sobue(Nagoya University), Naoki Atsuta(Nagoya University), Takayoshi Shimohata(Gifu University), Koji Fujita(Tokushima University), Masahiro Sonoo(Teikyo University), Tatsuo Kagimura(Foundation for Biomedical Research and Innovation), Hiroyuki Nodera(Tokushima University), Hidefumi Ito(Kyoto University), Daisuke Kuzume(Chikamori Hospital), Makoto Urushitani(Shiga University of Medical Science), Masaya Oda(Tokyo Metropolitan Neurological Hospital), Kazutoshi Nishiyama(Kitasato University), Mitsuya Morita(Fujita Health University), Nobuo Kohara(Kyoto University), Sagiri Isose(National Hospital Organization), Osamu Onodera(Niigata University), Shun Shimohama(Unknown), Toshio Shimizu(Tokyo Institute of Psychiatry), Koji Abe(Okayama University), Nobuyuki Araki(National Hospital Organization), Kazuaki Kanai(Chiba University), Kensuke Noma(Hiroshima University), Yasuhiro Kojima(Ijinkai Takeda General Hospital), Taiji Tsunemi(Juntendo University), Kiyonobu Komai(National Hospital Organization)
Cited by 83
Related Papers
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA)
|Nature Genetics|1994|1.1k